Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Equities, oil prices fall on concerns over Europe COVID-19 surge

Tue, 23rd Mar 2021 20:13

(Updates through close of U.S. trading)

By David Randall

NEW YORK, March 23 (Reuters) - World equity benchmarks and
oil prices drifted lower on Tuesday while safe-haven assets
gained as an extended economic lockdown in Germany and U.S. and
European sanctions on China curbed risk appetite.

Rising concerns over a third wave of the coronavirus
pandemic amid slow vaccine rollouts in Europe hurt oil and
travel companies as investors priced in a longer road to
economic recovery.

Germany extended its lockdown until April 18, and Chancellor
Angela Merkel urged citizens to stay at home for five days over
the Easter holiday.

U.S. crude fell 6.51% to $57.55 per barrel and Brent
was at $60.51, down 6.36% on the day.

Travel-related stocks fell as much as 4%.

"Global travel is still looking like it could be a while
away," said Matt Stanley, a fuel broker at Star Fuels in Dubai,
adding that a second-half recovery in oil demand looked doubtful
as lockdowns remain the order of the day.

MSCI's gauge of stocks across the globe shed
0.88% following broad declines in Europe and Asia.

On Wall Street, the Dow Jones Industrial Average fell
308.05 points, or 0.94%, to 32,423.15, the S&P 500 lost
30.07 points, or 0.76%, to 3,910.52 and the Nasdaq Composite
dropped 149.85 points, or 1.12%, to 13,227.70.

Benchmark 10-year notes rose 19/32 in price to
yield 1.6153%, from 1.682% late on Monday after Federal Reserve
Chair Jerome Powell and Treasury Secretary Janet Yellen spoke
before a congressional hearing.

In remarks prepared before the hearing, Powell said the U.S.
economic recovery had progressed "more quickly than generally
expected."

Republican members of the committee quizzed Yellen on how
the United States can simultaneously be in crisis and healthy
enough to consider raising taxes.

Once employment recovers from the pandemic, "President Biden
is likely to propose that we engage in long-term plans to
address longstanding investment shortfalls... in infrastructure,
investment to address climate risk, investments in people, R&D,
manufacturing," she said. "It is necessary to pay for them."

Steven Ricchiuto, US chief economist at Mizuho Securities
USA, said "Powell seemed to throw his weight toward Democratic"
suggestions that the Federal Reserve include climate risk as
part of their stress test for banks.

"For investors, it means this area of regulation will come
not only from the Treasury and Congress, but also likely the
Fed," he added.

The dollar index rose 0.612%, with the euro
down 0.72% to $1.1845.

Human rights sanctions on China imposed by the United
States, Europe and Britain, which prompted retaliatory sanctions
from Beijing, added to market concerns.

Worries over the pace of the recovery from the pandemic were
also heightened after a U.S. health agency said the AstraZeneca
Plc vaccine developed with Oxford University may have
included outdated information in its data.

Spot gold dropped 0.6% to $1,727.71 an ounce..

(Reporting by David Randall; Editing by Jane Merriman,
Bernadette Baum and Dan Grebler)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.